Search Browse Earnings

Scienture Holdings, Inc. — SlamSEC

Scienture Holdings, Inc.

Nasdaq:SCNX

Pharmaceutical Preparations·COMMACK, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

CEO

Shankar Hariharan

CFO

Patel Prashant

Revenue

$1.4M

-86.7% YoY

FY 2024

Adj. EBITDA

-$4.4M

-320.9% margin

FY 2024

Net Income

-$17.8M

-1308.3% margin

FY 2024

EPS (Diluted)

-$23.35

FY 2024

Stock Price

$0.47

-8.4%

2026-03-13

52W Range

$0.37 – $3.17

P/E Ratio

-0.0x

Market Cap

$19.0M

Cash

$1.1M

FY 2023

Total Debt

$2.9M

FY 2024

Net Debt

$1.8M

FY 2024

Enterprise Value

$20.8M

Debt / EBITDA

-0.4x

FY 2024

EV / EBITDA

-4.8x

Employees

—